Showbiz Cheat Sheet
2020 Showbiz Cheat Sheet,
All Rights Reserved.
Articles About bristol myers squibb
Top 5 Responsible Corporations in the U.S.
Immune Checkpoint Blocker Race Heats Up
Whisper Number: What Will Bristol-Myers’ Shares Do Post-Earnings?
Obesity Stock Plays That Stand Out From the Crowd
4 Mergers and Acquisitions Stock Stories for a Savvy Friday Read
4 Healthcare Stock Stories for Midweek Investment Wellness
Petrobras Pops on Good News from Libra Field and 2 Other How Stocks to Watch
4 Healthcare Stock Stories Gaining Thursday Traction
Whisper Number: How Will Bristol-Myers Stock Move After Earnings?
Analysts: Bristol-Myers Shows Pipeline Catalysts and 3 Other Research Notes to Look Over
Will Onyx Pharmaceuticals Continue to Rise?
Bristol-Myers’s Cancer Drug Lands This Brand New Partner
Whisper Number: Will Bristol-Myers Squibb Look Healthy?
Bristol-Myers Squibb Earnings: What Investors Should Watch
Bristol-myers Squibb Earnings Preview: Get Ahead of the Analysts
Bristol-Myers Squibb Fourth Quarter Earnings Sneak Peek
Bristol-Myers Squibb and Quest Diagnostics Facing Healthcare Hurdles
Bristol-Myers Squibb and Eli Lilly: The Patent Cliff Strikes Back
Bristol-Myers Squibb Earnings Sneak Peek
Abbott Labs Pops to New All-Time High After Clinical Results
Can Johnson & Johnson Beat Analysts’ Estimates?
Pfizer: Here’s How We are Combating Generic Drugs
Here’s How to Invest According to Paul Ryan’s Philosophy
Toyota Plans to DOUBLE Sales in Brazil and 4 Hot Stocks Fighting for Attention
Bristol-Myers Squibb Second Quarter Earnings Sneak Peek
Healthcare Biz Recap: Dendreon’s PREDICAMENT, Shionogi-ViiV’s TRIUMPH
HSBC to APOLOGIZE for Lapse and 2 Hot Stocks to Notice Now
Healthcare Wrap: BMY Begins Amylin BID, Arena JOYRIDE Goes ON
Mergers and Acquisitions Recap: Micron’s Buyout of Elpida CHALLENGED, Komatsu Doesn’t Want JOY
Healthcare Biz Review: Osiris ACCUSED, Chelsea’s BAD NEWS
Amylin Pharmaceutical POPS 8.9% with 4 Stocks Hitting 52-Week Highs
Healthcare Biz Recap: Glaxo TRICKS Doctors, Amylin BOUGHT By Two Firms
Astra-Zeneca Builds Appetite After Amylin Buy and 4 Stocks Sizzle Now
Afternoon BUZZERS: Dell and Bristol Play Dealmakers, Facebook’s FIRM Decision
Wall St. Brief: Barclays Chairman RESIGNS, Bristol-Myers Makes HUGE Acquisition
Stocks BUZZING Before the Bell: Zynga FAILS to Impress, Bristol-Myers’ Buyback
Healthcare Biz Recap: FDA PROBES Pfizer’s New Drug, Ventrus Biosciences ABANDONS Treatment
Ventrus Biosciences IMPLODES 58% and 4 Stocks with Horrible News Now
Healthcare Biz Recap: Dendreon’s SEC Inquiry, Bristol-Myers Squibb Hates Thursday
Healthcare Business Recap: Human Genome, Sequenom, Dendreon Shares Surge Higher
Wall Street Brief: Instagram Slams Shutterfly, Sony’s Big Loss
Healthcare Business Recap: Walgreen Continues Fall, Abbott Labs Promising Drug
Healthcare Business Recap: Amylin is a Darling, Teva Pharmaceuticals New Treatment
8 Buzzing Stocks: Google Prepares $150 Tablet, Krispy Kreme Approves $20 Million Repurchase Program
Healthcare Business Review: Critical Hep C Data on the Horizon, CVS Debacle
9 Buzzing Stocks: First Solar Surges 7%, While Gilead Sciences Plummets 16%
Gilead Up 6% After Positive Hep-C Trial
Mergers and Acquisitions: Bristol-Myers Squibb and Lions Gate in Focus
Abercrombie & Fitch, Oracle and Aflac Price Targets Cut; Bristol-Myers Squibb Buys Inhibitex
Healthcare Business Recap: J&J Halts Clinical Trial, Jazz Pharmaceuticals Revises Higher